Introducing the AI Biosecurity Lab - FirstWord Pharma
Advances in AI are creating unprecedented opportunities for scientific discovery, but they are also changing the biological risk landscape. AI can ...
FirstWord Pharma 19
Covers: HealthcareMarkets & InvestmentChina & GeopoliticsLegal & CourtsRegulation & PolicyCopyright & IPEducationAI Safety & Existential Risk
Beyang brings in ~$30M to advance AI -designed drug pair - FirstWord Pharma
The funding will help the Chinese biotech build out its AI design and optimisation platform, ExCEED, while moving two programmes produced by the ...
BrandLaunchX Launches AI Platform to Reduce Drug Launch Failures and Accelerate ...
BrandLaunchX Launches AI Platform to Reduce Drug Launch Failures and Accelerate Patient Access to Approved Therapies. Press Release. By: Ref: EIN ...
ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next ...
DeepExp (AUC=0.95): An AI model that accurately predicts secretory expression levels for full-length proteins in mammalian cells, overcoming a key ...
HSS Presents New Research Leveraging AI to Uncover Insights Related to Pain Risk and ...
Risk factors included elevated levels of certain inflammatory cytokines (proteins) in the blood, severe preoperative pain, and a longer period of ...
Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug ...
WASHINGTON and NESSA ZIONA, Israel, April 17, 2026 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses AI to transform ...
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in ...
WASHINGTON and NESS ZIONA, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Biolojic Design, a biotechnology company that uses AI to transform ...
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI -Driven ...
As China's chronic disease prevention and control system enters a critical stage of digital transformation, industry participants are shifting from a ...
Brand Engagement Network Finalizes Agreement for a Proprietary AI ... - FirstWord Pharma
Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the ...
Bexorg wins $23M to end CNS drug trial failures using AI — and human brains
... failures using AI — and human brains. Yale University spin-out Bexorg on Wednesday closed a $23-million series A to enhance its AI -driven whole ...
AI -enabled stethoscope accurately flags patients at risk for heart failure - FirstWord Pharma
VIRTUAL -- August 29, 2025 -- A prospective validation study across 23 UK primary care practices found that an artificial intelligence ...
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
... risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's ...
Copyright & IPRegulation & PolicyMarkets & InvestmentLegal & Courts
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
... AI , its artificial intelligence –powered drug discovery and development program. ... risks , delays, uncertainties and other factors not under the ...
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation ...
Redwood AI's platform has the potential to enable us to explore synthesis strategies, evaluate risks , and optimize compound design with greater speed ...
Investors Rekindle Interest in China's AI Pharma Sector, Though Tangible Results Are Yet to Come
Investor interest in China's AI -driven pharmaceutical sector is resurging, though the industry has yet to deliver clear, transformative outcomes, ...
Tevogen Details its Artificial Intelligence Initiative, Tevogen. AI ; Proprietary AI -Powered ...
... risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's ...
Copyright & IPRegulation & PolicyMarkets & InvestmentLegal & Courts
AI -Backed Saliva Test Shows Promise for Flagging Chemo Risk - FirstWord Pharma
Virginia Tech researchers John Janiga, Dzenis Mahmutovic (seated), Katherine Brown, and lead investigator Carla Finkielstein work together in the ...
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a ...
This announcement marks the third foundational support pillar for Tevogen. AI , the Company's AI initiative which aims to transform precision medicine:.
ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI -Driven Platform LENSai ...
Immunogenicity Screening: The platform identifies immunogenic hotspots and predicts potential adverse immune responses, reducing the risk of anti-drug ...